الولايات المتحدة · منصات وبيانات · Yahoo Finance

Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer

نشره Yahoo Finance · الولايات المتحدة منذ 8 س

STAMPEDE study analysis providing new predictive evidence in clinically very high-risk, nonmetastatic disease to be presented at ESMOSOUTH SAN FRANCISCO, Calif., Oct. 23, 2026…

اقرأ المقال كاملًا على Yahoo Finance سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (finance.yahoo.com)

يستحق القراءة أيضًا

MarketBeat

2,406 International Business Machines Corporation $IBM Shares Sold by Culbertson A N & Co. Inc.

The Motley Fool

The Federal Reserve's Latest October Inflation Forecast Has Arrived, and It's Terrible News for Wall Street

Seeking Alpha

Eurozone flash composite PMI falls to 51.9 in October; services, and manufacturing expansion slows

MarketWatch

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Investing.com

Kemira Q3 2026 slides: revenue rises but margins hit by cost inflation

Stocktwits